- Abstract Number: 0419
Ultrasound-Guided Synovial Biopsy in Children and Adolescents with Juvenile Arthritis: Initial Results
- Abstract Number: 0936
Ultrasound-Mediated Blood–Brain Barrier Permeabilization Enables Targeted Drug Delivery in a Murine Model of Neuropsychiatric SLE
- Abstract Number: 0521
Umbilical cord-derived mesenchymal stem cells suppress the pathogenesis of primary Sjögren’s disease by inducing Bach2 expression
- Abstract Number: 2321
Uncovering Clinical Phenotypes of Sexual Dysfunction in Spondyloarthritis: A Multidimensional Analysis
- Abstract Number: 0349
Underrecognized Glucocorticoid-Induced Osteoporosis in a Polymyalgia Rheumatica Patient Cohort
- Abstract Number: 1402
Understanding Fatigue Through Patients’ Eyes: Development of a Novel Questionnaire Capturing the Complexity of Real-Life Fatigue in Sjögren’s Disease
- Abstract Number: 2660
Understanding Gout in Women: Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause
- Abstract Number: 1426
Understanding the Drivers of BASDAI and Back Pain Scores in Psoriatic Arthritis
- Abstract Number: 2691
Understanding the Impact of Overweight and Obesity on Treatment Response in Psoriatic Arthritis: Results from a Longitudinal Cohort Study
- Abstract Number: 0068
Unique Fibroblast-like Synoviocyte Phenotype with Elevated MCSF Expression Induced by TLR5 Activation in Rheumatoid Arthritis
- Abstract Number: 2647
Unlinked Paths to SLE: Divergent Associations of DNA Methylation and Polygenic Risk Scores with SLE Features
- Abstract Number: 2490
Unmasking Mortality Risk: The Impact of Systemic Sclerosis in Stress-Induced Cardiomyopathy
- Abstract Number: 1859
Unraveling Disparities in Systemic Lupus Erythematosus-Related Mortality Among U.S. Adults (≥25 Years) with Malignancy: A Longitudinal Analysis of Gender, Race, and Geographic Inequities Using CDC WONDER (1999–2020)”
- Abstract Number: 2489
Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
- Abstract Number: 2497
Unraveling the Complexity of Interferon Responses in Peripheral Blood Mononuclear Cells in Systemic Sclerosis at Single-Cell Resolution
- Abstract Number: 0971
Unraveling the role of the hippo pathway in systemic sclerosis: A focus on TEADs and VGLL3
- Abstract Number: 0071
Unravelling Transcriptomic Landscapes in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Shared and Unique Molecular Signatures related to relevant clinical features.
- Abstract Number: 1088
Unsupervised characterization of immune checkpoint inhibitor induced inflammatory arthritis using cluster and latent class analysis: result from a multicenter prospective registry
- Abstract Number: 0543
Unveiling Sacroiliac Joint Involvement in Psoriatic Arthritis: MRI, Radiographic, and Clinical Insights from 581 European Routine Care Patients
- Abstract Number: 2474
Unveiling the clinical spectrum of ACA-positive SSc-ILD: not as benign as expected
- Abstract Number: 1258
Upadacitinib in the treatment of Rheumatoid Arthritis – Interstitial Lung Disease. National multicenter study of 25 patients in clinical practice.
- Abstract Number: 1529
Updated Phase 1 Trial Data Assessing the Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BMS-986353 (CC-97540), a CD19-directed Chimeric Antigen Receptor T Cell Therapy Using a Next-Generation Process for Severe, Refractory SLE
- Abstract Number: 2304
Updates in the local treatments in Primary Sjögren’s Syndrome “Efficacy and Safety”
- Abstract Number: 1345
Upregulated TLR Signaling Identified in Difficult-to-Treat RA: A Propensity Score–Matched Transcriptome Study
- Abstract Number: 1480
Urinary Biomarkers Detect Proliferative Lupus Nephritis in SLE Patients with Subclinical Proteinuria.
- Abstract Number: 1750
Urinary Proteomic Signature Identifies Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- Abstract Number: 0851
Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis
- Abstract Number: 0302
Urine Kynurenine Pathway Biomarkers Correlate with Disease Activity and Damage Core Set Measures in JDM
- Abstract Number: 1356
Use of (MSB11456), the first tocilizumab biosimilar approved for rheumatoid arthritis: 6-month data from an international observational study
- Abstract Number: 0686
Use of a Smartphone App which Incorporates Feedback to Patients to Monitor Systemic Sclerosis-related Digital Ulcers – a Potential New Tool for Remote Clinical Monitoring
- Abstract Number: 0234
Use of Corneal Confocal Microscopy to Assess Small Fiber Neuropathy in Patients with Sarcoidosis
- Abstract Number: 1598
Use of JAK Inhibitors in Medium- and Small-Sized Vasculitides: a Retrospective Multicenter Study
- Abstract Number: 1618
Use of JAK inhibitors in patients with refractory Takayasu arteritis: A worldwide retrospective study
- Abstract Number: 2301
Use of lived experiences in childhood Sjogren Disease to develop outcome measures for an N-of-1 treatment trial.
- Abstract Number: 0247
Use of Nintedanib in Patients with Progressive Pulmonary Fibrosis
- Abstract Number: 1355
Use of parenteral compared to oral glucocorticoids in early rheumatoid arthritis is superior for chance ofbeing off steroids and escalation of therapy at 1 year
- Abstract Number: 1261
Use of telemedicine to address ‘off target’ symptoms in psoriatic arthritis (PsA): implementation of PsOWell™ in PsA
- Abstract Number: 1578
Use of the CD19/CD3 T cell engager blinatumomab in refractory diffuse systemic sclerosis : a case series
- Abstract Number: 0505
Use of Upadacitinib in Real-World Clinical Practice: Patient Characteristics and Glucocorticoid-Sparing Effect
- Abstract Number: 2446
Use of Voclosporin in Pediatric Patients: A Summary of Available Data from Post-marketing Reports
- Abstract Number: 1561
Usefulness of HRCT in screening of interstitial lung disease in patients with systemic sclerosis without risk factors of clinical suspicion
- Abstract Number: 2566
Using Abdominal CT-Derived Bone Mineral Density and Psoas Volume for Opportunistic Osteoporosis Screening and Fracture Risk Assessment
- Abstract Number: 0794
Using Artificial Intelligence to Analyze Multilingual Qualitative Data in Lupus Pregnancy Research: A Proof of Concept with Large Language Models
- Abstract Number: 2174
Using Natural Language Processing to Identify Character Strengths in Rheumatology Fellowship Candidate Applications: A Feasibility Study
- Abstract Number: 0994
UTAA91: An Off-the-Shelf Allogeneic CAR-Vδ1T Therapy Leveraging CD19 Nanoantibody for B-cell Depletion and PD-1 Agonist Nanoantibody for Pathogenic T-cell Elimination in Refractory Autoimmune Diseases
- Abstract Number: 1979
Utility of ALT/AST and Fibrosis-4 Index (FIB-4) Score in Monitoring Methotrexate Hepatotoxicity in Rheumatologic Disease: A Retrospective Analysis
- Abstract Number: 0716
Utility of Follow-Up Cardiac Magnetic Resonance Imaging In Patients With Eosinophilic Granulomatosis With Polyangiitis
- Abstract Number: 0195
Utility of Repeat ANA Testing
- Abstract Number: 0827
Utilization of American College of Rheumatology Vaccination Guidelines in Clinic: A Needs Assessment in an Internal Medicine Residency Program
- Abstract Number: 2046
Utilization of the All of Us Research Program to Study the Impact of Genetic Background on Autoinflammatory Diseases
- Abstract Number: 1978
Utilizing a Gap to Target Function in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry Dashboard of Quality Measures
- Abstract Number: 2194
Utilizing Case-Based Learning to Teach the Teacher and Improve Health Insurance Literacy
- Abstract Number: 0916
UVB-Irradiated Keratinocyte Extracellular Vesicles Trigger Innate Immune Activation via Type I Interferons and STING Pathway
ACR Convergence 2025
October 24-29, 2025. Chicago, Illinois.